DBV Technologies | Gewinn Vor Steuern



Pre Tax Profit Veränderung Datum
Acadia Pharmaceuticals USD 161.08M 122.28M 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amarin USD -21529000 24.42M 2024-09
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
DBV Technologies EUR -30442000 2.67M 2024-09
Halozyme Therapeutics USD 557.13M 359.8M 2024-12
Incyte USD 406.83M 147.12M 2024-12
Insmed USD -234282000 14.77M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 396.5M 7.9M 2024-12



DBV Technologies Gewinn Vor Steuern - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.